Affiliations: Department of Cancer Biology, The University of Texas
M.D. Anderson Cancer Center. Houston, USA
Note: [] Address for correspondence: Catherine A. OBrian
Department of Cancer Biology The University of Texas M.D. Anderson Cancer
Center 1515 Holcombe Boulevard, Box 173 Houston, TX 77030, USA Telephone
713-792-7969 Telefax 713-792-8747 Email [email protected]
Note: []
Abstract: Protein kinase C (PKC) is an extensive isozyme family that plays
critical roles in cell growth regulation and differentiation and in specialized
physiological processes such as neurotransmission. The regulation of PKC
isozymes is complex not only due to the existence of isozyme-selective
regulatory mechanisms but also due to the fact that multiple regulatory
mechanisms may contribute to the governance of the function of a given isozyme.
Most PKC isozymes require trans-phosphorylation by phosphoinositide-dependent
kinase-1 (PDK1) to become catalytically competent and stimulation by lipid
cofactors (in some cases in conjunction with Ca2+) to be activated. At least
two PKC isozymes, d and q, can be proteolytically converted in cells to
lipid-independent activated forms that participate in cell signaling. In
addition, evidence is now emerging that oxidative stimuli may induce PKC
activation in cells under certain conditions via tyrosine phosphorylation of
the isozymes, and that under other conditions the oxidants may inactivate PKC
isozymes by oxidative modification of Cys residues in the catalytic domain.
Isozyme-selective binding proteins that direct the localization of PKC isozymes
offer yet another level of regulatory control over PKC signaling.
Keywords: protein kinase C, isoenzymes, trans-phosphorylation